The Journal of Cell Biology · 2000 · 109 citations · 20 references
Life SciencesEndocrinologyOncologyCell SignalingMolecular OncologySteroid BiochemistryGonadal HormonesGonadal Steroid HormonesHormone ReceptorsHormone SignalingProstate CancerSteroid Hormone SignalingAndrogen Receptor Co-regulatorsAndrogen Receptor RegulationAndrogen ReceptorsAnti-androgen ResistanceCyclin OverexpressionCyclin RegulationProstate Cancer Hormonal TherapySignal Transactivation
Androgens play an important role in the growth of prostate cancer, but the molecular mechanism that underlies development of resistance to antiandrogen therapy remains unknown. Cyclin E has now been shown to increase the transactivation activity of the human androgen receptor (AR) in the presence of its ligand dihydrotestosterone. The enhancement of AR activity by cyclin E was resistant to inhibition by the antiandrogen 5-hydroxyflutamide. Cyclin E was shown to bind directly to the COOH terminus portion of the AB domain of the AR, and to enhance its AF-1 transactivation function. These results suggest that cyclin E functions as a coactivator of the AR, and that aberrant expression of cyclin E in tumors may contribute to persistent activation of AR function, even during androgen ablation therapy.
20
T. Tong, S. Bolden, Phyllis A. Wingo · CA A Cancer Journal for Clinicians · 1996 · 1.8K citations · Full text
Medicine, Biostatistics, Oncology +17
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Renate M.L. Zwijsen, Ellen Wientjens, Rob Klompmaker et al. · Cell · 1997 · 717 citations · Full text